BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8885849)

  • 41. Derivation of primary sequences and secondary structures of rev responsive element from HIV-1 infected mothers and infants following vertical transmission.
    Ramakrishnan R; Ahmad N
    Virology; 2007 Mar; 359(1):201-11. PubMed ID: 17045321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
    Litovchick A; Rando RR
    RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids.
    Olsen HS; Cochrane AW; Dillon PJ; Nalin CM; Rosen CA
    Genes Dev; 1990 Aug; 4(8):1357-64. PubMed ID: 2227413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):49-51. PubMed ID: 8643395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides.
    Chin DJ
    J Virol; 1992 Jan; 66(1):600-7. PubMed ID: 1727504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
    Stauber RH; Afonina E; Gulnik S; Erickson J; Pavlakis GN
    Virology; 1998 Nov; 251(1):38-48. PubMed ID: 9813201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex.
    Tan R; Frankel AD
    Biochemistry; 1994 Dec; 33(48):14579-85. PubMed ID: 7981219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted cleavage of HIV rev response element RNA by metallopeptide complexes.
    Jin Y; Cowan JA
    J Am Chem Soc; 2006 Jan; 128(2):410-1. PubMed ID: 16402818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamics of RNA-protein interactions in the HIV-1 Rev-RRE complex visualized by 6-thioguanosine-mediated photocrosslinking.
    Ping YH; Liu Y; Wang X; Neenhold HR; Rana TM
    RNA; 1997 Aug; 3(8):850-60. PubMed ID: 9257644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incorporation of a non-nucleotide bridge into hairpin oligonucleotides capable of high-affinity binding to the Rev protein of HIV-1.
    Nelson JS; Giver L; Ellington AD; Letsinger RL
    Biochemistry; 1996 Apr; 35(16):5339-44. PubMed ID: 8611522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
    Lacourciere KA; Stivers JT; Marino JP
    Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication.
    Sherpa C; Rausch JW; Le Grice SF; Hammarskjold ML; Rekosh D
    Nucleic Acids Res; 2015 May; 43(9):4676-86. PubMed ID: 25855816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.
    Kumar S; Bose D; Suryawanshi H; Sabharwal H; Mapa K; Maiti S
    PLoS One; 2011; 6(8):e23300. PubMed ID: 21853108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolvability of the mode of peptide binding by an RNA.
    Iwazaki T; Li X; Harada K
    RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs.
    Battiste JL; Tan R; Frankel AD; Williamson JR
    Biochemistry; 1994 Mar; 33(10):2741-7. PubMed ID: 8130185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circular dichroism studies of the HIV-1 Rev protein and its specific RNA binding site.
    Daly TJ; Rusche JR; Maione TE; Frankel AD
    Biochemistry; 1990 Oct; 29(42):9791-5. PubMed ID: 2125482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene.
    Ward AM; Rekosh D; Hammarskjold ML
    J Virol; 2009 Jan; 83(2):940-52. PubMed ID: 18971264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.
    Tiley LS; Malim MH; Tewary HK; Stockley PG; Cullen BR
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):758-62. PubMed ID: 1731351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.